386 related articles for article (PubMed ID: 21306315)
1. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management.
Kirk E; Van Calster B; Condous G; Papageorghiou AT; Gevaert O; Van Huffel S; De Moor B; Timmerman D; Bourne T
Acta Obstet Gynecol Scand; 2011 Mar; 90(3):264-72. PubMed ID: 21306315
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy.
Mavrelos D; Nicks H; Jamil A; Hoo W; Jauniaux E; Jurkovic D
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):102-7. PubMed ID: 23303651
[TBL] [Abstract][Full Text] [Related]
4. How feasible is expectant management of interstitial ectopic pregnancy?
Poon LC; Emmanuel E; Ross JA; Johns J
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):317-21. PubMed ID: 23868814
[TBL] [Abstract][Full Text] [Related]
5. β-hCG resolution times during expectant management of tubal ectopic pregnancies.
Mavrelos D; Memtsa M; Helmy S; Derdelis G; Jauniaux E; Jurkovic D
BMC Womens Health; 2015 May; 15():43. PubMed ID: 25994203
[TBL] [Abstract][Full Text] [Related]
6. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study.
Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360
[TBL] [Abstract][Full Text] [Related]
7. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
8. Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis.
Elson J; Tailor A; Banerjee S; Salim R; Hillaby K; Jurkovic D
Ultrasound Obstet Gynecol; 2004 Jun; 23(6):552-6. PubMed ID: 15170794
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Ultrasonographic and Biochemical Markers of Tubal Ectopic Pregnancy and Success of Subsequent Management.
Nadim B; Lu C; Infante F; Reid S; Condous G
J Ultrasound Med; 2018 Dec; 37(12):2899-2907. PubMed ID: 29675930
[TBL] [Abstract][Full Text] [Related]
10. Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study.
Helmy S; Mavrelos D; Sawyer E; Ben-Nagi J; Koch M; Day A; Jurkovic D
PLoS One; 2015; 10(7):e0130598. PubMed ID: 26135923
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
[TBL] [Abstract][Full Text] [Related]
12. Serum β-hCG levels post-treatment of ectopic pregnancy with a single dose of intramuscular methotrexate.
Hadinata IE; Doyle LW; Thompson D; Reti L
Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):181-4. PubMed ID: 25898911
[TBL] [Abstract][Full Text] [Related]
13. [Relative factors of expectant management of ectopic pregnancy].
Qi XY; Su SL; Dong BH
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(15):1165-7. PubMed ID: 23902889
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
[TBL] [Abstract][Full Text] [Related]
15. Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG.
Levin G; Dior U; Shushan A; Gilad R; Benshushan A; Rottenstreich A
Reprod Biomed Online; 2019 Jul; 39(1):149-154. PubMed ID: 31029556
[TBL] [Abstract][Full Text] [Related]
16. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin.
Cohen A; Bibi G; Almog B; Tsafrir Z; Levin I
Fertil Steril; 2014 Dec; 102(6):1646-9. PubMed ID: 25241368
[TBL] [Abstract][Full Text] [Related]
17. Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success.
Wu J; Ludlow JP; De Vries B; Black K; Beale P
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):469-74. PubMed ID: 25287564
[TBL] [Abstract][Full Text] [Related]
18. Predictors of methotrexate treatment failure in ectopic pregnancy.
Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of maternal serum biomarkers in predicting outcome of successful expectant management of tubal ectopic pregnancies.
Memtsa M; Jauniaux E; Gulbis B; Jurkovic D
Eur J Obstet Gynecol Reprod Biol; 2020 Jul; 250():61-65. PubMed ID: 32387894
[TBL] [Abstract][Full Text] [Related]
20. Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy.
Corsan GH; Karacan M; Qasim S; Bohrer MK; Ransom MX; Kemmann E
Hum Reprod; 1995 Oct; 10(10):2719-22. PubMed ID: 8567799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
